Role of decongestants in a complex therapy of acute infectious rhinitis

Nowadays the problem of treating of acute respiratory viral infections, primarily manifested with the clinical picture of acute rhinitis, remains an important problem due to the high prevalence and variety of etiological factors of this disease. Pathogenesis of rhinitis, regardless of the etiology, includes the swelling of the nasal mucosa, the increase in nasal secretion, which blocks nasal breathing and significantly reduces the quality of life. In uncomplicated forms of acute infectious rhinitis, symptomatic treatment is traditionally used, including the elimination therapy and drugs for reducing the nasal mucosa swelling. Topical decongestants have a sympathomimetic effect, affect α1- and α2-adrenergic receptors and help to eliminate swelling of the nasal mucosa and improve nasal breathing, and as a result, restore the patency and aerodynamics of the airways, recover the drainage function of the paranasal sinuses and auditory tube. To date, the pharmaceutical market offers many intranasal decongestants that differ in the duration of exposure, frequency of use, the occurrence of side effects or adverse events. The article shows the pharmacological and pharmacokinetic characteristics of the drug xylometazoline, highlights the results of Russian and foreign studies that demonstrate the efficacy and good tolerability of xylometazoline with a short-term topical course of treatment. The conclusion is made about a good profile of the efficacy and safety of the drug and confirmed that in compliance with the recommendations for the frequency and duration of application, xylometazoline could be recommended for use in a complex symptomatic treatment of acute rhinitis in adults and children.

1. Lytkina I.N., Malyshev N.A. Prevention and treatment of influenza and acute respiratory viral infections among epidemiologically significant population groups. Lechashchiy vrach = Lechaschi Vrach Journal. 2010;10:66–69. (In Russ.) Available at: https://www.lvrach.ru/2010/10/15435060/.

2. Krantz E.M., Zier J., Stohs E. Ogimi C., Sweet A., Marquis S. et al. Antibiotic Prescribing and Respiratory Viral Testing for Acute Upper Respiratory Infections Among Adult Patients at an Ambulatory Cancer Center. Clin Infect Dis. 2020;70(7):1421–1428. doi: 10.1093/cid/ciz409.

3. Kardos P., Malek F. Common Cold – an Umbrella Term for Acute Infections of Nose, Throat, Larynx and Bronchi. Pneumologie. 2016;71(4):221–226. doi: 10.1055/s-0042-116112.

4. Baranov A.A., Lobzin Yu.V., Namazova-Baranova L.S., Tatochenko V.K., Uskov A.N., Kulichenko T.V. et al. Аcute respiratory viral infection in children: modern approaches to diagnosis and treatment. Pediatricheskaya farmakologiya = Pediatric Pharmacology. 2017;2(14):100–108. (In Russ.) doi: 10.15690/pf.v14i2.1724.

5. Кryuchko T.A., Kushnereva T.V., Ostapenko V.P., Kolenko I.A. Problematic issues of outpatient management of children with acute respiratory viral infections. Sovremennaya pediatriya. 2014;(8):65. (In Russ.) Available at: https://med-expert.com.ua/problemnye-voprosy-ambulatornogo-vedenijadetej-s-ostrymi-respiratornymi-virusnymi-infekcijami/.

6. Bartlett J.G. Management of Respiratory Tract Infections. Philadelphia: Lippincott Williams & Wilkin; 1999.

7. Markova T.P. Prevention and treatment of respiratory infections. RMZH = RMJ. 2010;(2):77–82. (In Russ.) Available at: https://www.rmj.ru/articles/infektsiya/Profilaktika_i_lechenie_respiratornyh_infekciy/.

8. Gorenkov R.V., Kruglov V.A. Diagnosis and Treatment of Acute Respiratory Diseases. Effektivnaya farmakoterapiya = Effective Pharmacotherapy. 2018;(10):24–34. (In Russ.) Available at: https://elibrary.ru/item.asp?id=34943060.

9. Svistushkin V.M., Nikiforova G.N., Shevchik E.A., Dedova M.G Use of intranasal drugs in the treatment of patients with acute infectious rhinitis. RMZH = RMJ. 2014;(26):1903–1907. (In Russ.) Available at: https://www.rmj.ru/articles/otorinolaringologiya/Ispolyzovanie_intranazalynyh_preparatov_v_lechenii_bolynyh_ostrym_infekcionnym_rinitom.

10. Lopatin A.S. Rhinitis: a guide for physicians. Moscow: Litterra; 2010. 424 p. (In Russ.) Available at: https://www.rosmedlib.ru/book/ISBN9785904090302.html.

11. Radtsig E., Ermilova N., Sapaeva N., Bogomil’sky M. Alternative to topical decongestants for symptomatic treatment of children’s acute rhinitis. Voprosy Sovremennoi Pediatrii = Current Pediatrics. 2007;6(5):92–95. (In Russ.) Available at: https://vsp.spr-journal.ru/jour/article/view/1288.

12. Krivopalov A.A., Ryazansev S.V., Shamkina P.A. Complex homeopathic therapy of acute infectious rhinitis. Meditsinskiy sovet = Medical Council. 2019;(8):38–42. (In Russ.) doi: 10.21518/2079-701X-2019-8-38-42.

13. Deckx L., De Sutter A.I., Guo L., Mir N.A., van Driel M.L. Nasal decongestants in monotherapy for the common cold. Cochrane Database Syst Rev. 2016;10(10):CD009612. doi: 10.1002/14651858.CD009612.pub2.

14. Zhukova L. Differential diagnosis, treatment and prevention of acute respiratory viral infections. Vrach. 2010;(10):2–6. (In Russ.) Available at: http://lor.rusvrach.ru/archive/vrach-2010-10-01.pdf.

15. Pivneva N.D., Kotova E.N., Radzig E.Y. Therapy of acute rhinitis in infants. Practika pediatra = Paediatrician Practice. 2013;(6):43–47. (In Russ.) Available at: https://medi.ru/docplus/j01131243.pdf.

16. Corboz M.R., Mutter J.C., Rivelli M.A., Mingo G.G., McLeod R.L., Varty L. et al. alpha2-adrenoceptor agonists as nasal decongestants. Pulm Pharmacol Ther. 2007;20(2):149–156. doi: 10.1016/j.pupt.2006.03.012.

17. Haenisch B., Walstab J., Herberhold S., Bootz F., Tschaikin M., Ramseger R., Bönisch H. Alpha-adrenoceptor agonistic activity of oxymetazoline and xylometazoline. Fundam Clin Pharmacol. 2010;24(6):729–739. doi: 10.1111/j.1472-8206.2009.00805.x.

18. Karpishchenko S.A., Kolesnikova O.M. Pros and cons of nasal decongestants. Consilium Medicum. Pediatrics (Suppl.). 2016;(3):31–36. (In Russ.) Available at: https://cyberleninka.ru/article/n/plyusy-i-minusy-nazalnyh-dekongestantov.

19. Grischenko E.B. Nasal decongestants in otorhinolaryngology. Meditsinskiy sovet = Medical Council. 2012;2:28–31. (In Russ.) Available at: https://cyberleninka.ru/article/n/nazalnye-dekongestanty-v-otorinolaringologii.

20. Fokkens W.J., Lund V.J., Hopkins C., Hellings P.W., Kern R., Reitsma S. et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(Suppl. 29):1–464. doi: 10.4193/Rhin20.600.

21. Karpishchenko S.A., Lavrenova G.V., Shakhnazarov A.E., Muratova E.I. Acute and chronic rhinosinusitis: additional opportunities for conservative therapy. Zhurnal otorinolaringologii i respiratornoy patologii = Folia Otorhinolaryngologiae et Pathologiae Respiratoriae. 2018;24(4):62–68. (In Russ.) Available at: https://foliaopr.spb.ru/wp-content/uploads/2018/04/Folia_24_4_2018.pdf.

22. Pshenichaya E.V., Dudchak A.P., Usenko N.A. Decongestants and their side effects for treatment of acute rhinitis in children (clinical example). Mat i ditya v Kuzbasse = Mother and Baby in Kuzbass. 2018;(3):50–53. (In Russ.) Available at: https://elibrary.ru/item.asp?id=35588248.

23. Kiselev A.B., Chaukina V.A. Reducing the load decongestants in the treatment of acute infectious rhinopharyngitis in children. Rossijskaya otorinolaringologia = Russian Otorhinolaryngology. 2018;(2):135–139. (In Russ.) doi: 10.18692/1810-4800-2018-2-135-139.

24. Gubin M.M., Azmetova G.V. New xylomethazoline formulation. Farmatsiya = Pharmacy. 2009;(7):29–31. (In Russ.) Available at: https://elibrary.ru/item.asp?id=13045968.

25. Tulupov D.A. Acute rhinitis in children. Voprosy sovremennoy pediatrii = Current Pediatrics. 2012;11(5):124–129. (In Russ.) doi: 10.15690/vsp.v11i5.440.

26. Chiba Y., Matsuo K., Sakai H., Abe K., Misawa M. Regional differences in vascular responsiveness of nasal mucosae isolated from naive guinea pigs. Auris Nasus Larynx. 2007;34(2):197–201. doi: 10.1016/j.anl.2006.09.014.

27. Graf P., Eccles R., Chen S. Efficacy and safety of intranasal xylometazoline and ipratropium in patients with common cold. Expert Opinion on Pharmacotherapy. 2009;10(5):889–908. doi: 10.1517/14656560902783051.

28. Eccles R., Eriksson M., Garreffa S., Chen S.C. The nasal decongestant effect of xylometazoline in the common cold. Am J Rhinol. 2008;22(5):491–496. doi: 10.2500/ajr.2008.22.3202.

29. Eccles R., Martensson K., Chen S.C. Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold. Curr Med Res Opin. 2010;26(4):889–899. doi: 10.1185/03007991003648015.

30. Eskiizmir G., Hirçin Z., Özyurt B., Ünlü H. A comparative analysis of the decongestive effect of oxymetazoline and xylometazoline in healthy subjects. Eur J Clin Pharmacol. 2011;67(1):19–23. doi: 10.1007/s00228-010-0941-z.